CN1133291A - 新的红霉素衍生物及其制备方法和药物用途 - Google Patents
新的红霉素衍生物及其制备方法和药物用途 Download PDFInfo
- Publication number
- CN1133291A CN1133291A CN95121426A CN95121426A CN1133291A CN 1133291 A CN1133291 A CN 1133291A CN 95121426 A CN95121426 A CN 95121426A CN 95121426 A CN95121426 A CN 95121426A CN 1133291 A CN1133291 A CN 1133291A
- Authority
- CN
- China
- Prior art keywords
- formula
- compound
- definition
- group
- methyl
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H17/00—Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals
- C07H17/04—Heterocyclic radicals containing only oxygen as ring hetero atoms
- C07H17/08—Hetero rings containing eight or more ring members, e.g. erythromycins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Molecular Biology (AREA)
- Biochemistry (AREA)
- Genetics & Genomics (AREA)
- Biotechnology (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Communicable Diseases (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Oncology (AREA)
- Saccharide Compounds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
Description
Claims (16)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR9414807A FR2727969B1 (fr) | 1994-12-09 | 1994-12-09 | Nouveaux derives de l'erythromycine, leur procede de preparation et leur application comme medicaments |
FR9414807 | 1994-12-09 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN1133291A true CN1133291A (zh) | 1996-10-16 |
CN1067077C CN1067077C (zh) | 2001-06-13 |
Family
ID=9469625
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN95121426A Expired - Lifetime CN1067077C (zh) | 1994-12-09 | 1995-12-08 | 新的红霉素衍生物及其制备方法和药物用途 |
Country Status (14)
Country | Link |
---|---|
US (1) | US5786339A (zh) |
EP (1) | EP0716093B1 (zh) |
JP (1) | JP4083824B2 (zh) |
KR (1) | KR100371473B1 (zh) |
CN (1) | CN1067077C (zh) |
AT (1) | ATE172467T1 (zh) |
AU (1) | AU697876B2 (zh) |
CA (1) | CA2164798C (zh) |
DE (1) | DE69505487T2 (zh) |
DK (1) | DK0716093T3 (zh) |
ES (1) | ES2123934T3 (zh) |
FR (1) | FR2727969B1 (zh) |
HU (1) | HU215192B (zh) |
ZA (1) | ZA9510447B (zh) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN100351238C (zh) * | 1998-11-10 | 2007-11-28 | 艾文蒂斯药品公司 | 新的红霉素衍生物、其制备方法和作为药物的用途 |
Families Citing this family (22)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2745290B1 (fr) * | 1996-02-28 | 1998-04-03 | Roussel Uclaf | Nouveaux derives de l'erythromycine, leur procede de preparation et leur application comme medicaments |
USRE38520E1 (en) * | 1996-02-28 | 2004-05-18 | Aventis Pharma S.A. | Erythromycin derivatives, method for preparing same, and use thereof as drugs |
DE19652362A1 (de) | 1996-12-17 | 1998-06-18 | Thomson Brandt Gmbh | Verfahren und Vorrichtung zur Kompensation der durch die Verarbeitung von Chrominanz-Signalen entstehenden Luminanzdefekte |
US5955440A (en) * | 1998-03-27 | 1999-09-21 | Abbott Laboratories | Macrolide LHRH antagonists |
US5972898A (en) * | 1998-03-27 | 1999-10-26 | Abbott Laboratories | 3',3-N-bis-substituted macrolide LHRH antagonists |
US6387885B1 (en) * | 1998-08-26 | 2002-05-14 | Abbott Laboratories | 3′,3′-N-bis-desmethyl-3′-N-cycloalkyl erythromycin derivatives as LHRH antagonists |
US6020521A (en) * | 1998-08-26 | 2000-02-01 | Abbott Laboratories | Macrolide LHRH antagonists |
EP1115732B1 (en) | 1998-09-22 | 2005-06-29 | Pfizer Products Inc. | Carbamate and carbazate ketolide antibiotics |
FR2786188B1 (fr) * | 1998-11-24 | 2002-10-31 | Hoechst Marion Roussel Inc | Nouveaux derives de l'erythromycine, leur procede de preparation et leur applicaion comme medicaments |
ATE344269T1 (de) | 1998-12-10 | 2006-11-15 | Pfizer Prod Inc | Carbamat und carbazat ketolid antibiotika |
BR9916969A (pt) * | 1999-01-27 | 2001-11-06 | Pfizer Prod Inc | Antibióticos cetólidos |
AU3832100A (en) * | 1999-05-24 | 2000-12-12 | Pfizer Products Inc. | 13-methyl-erythromycin derivatives |
AU6183700A (en) * | 1999-08-06 | 2001-03-05 | Taisho Pharmaceutical Co., Ltd. | Erythromycin a derivatives |
AU6183800A (en) * | 1999-08-06 | 2001-03-05 | Taisho Pharmaceutical Co., Ltd. | Erythromycin a derivatives |
WO2001010879A1 (en) * | 1999-08-06 | 2001-02-15 | Taisho Pharmaceutical Co., Ltd. | Erythromycin a derivatives |
ID27331A (id) * | 1999-09-29 | 2001-03-29 | Pfizer Prod Inc | Pembuatan antibiotik-antibiotik ketolida karbamat |
TWI283577B (en) * | 1999-10-11 | 2007-07-11 | Sod Conseils Rech Applic | Pharmaceutical composition of imidazole derivatives acting as modulators of sodium channels and the use thereof |
EP1146051A3 (en) * | 2000-04-10 | 2001-10-31 | Pfizer Products Inc. | Erythromycin A derivatives |
US20050014706A1 (en) * | 2003-07-14 | 2005-01-20 | Kanakeshwari Falzari | Method of treating tuberculosis |
RU2397987C2 (ru) * | 2004-07-28 | 2010-08-27 | Рэнбакси Лабораториз Лимитед | Кетолидные производные в качестве антибактериальных агентов |
PT1836211E (pt) * | 2004-12-21 | 2010-04-08 | Pfizer Prod Inc | Macrólidos |
US10130465B2 (en) | 2016-02-23 | 2018-11-20 | Abbott Cardiovascular Systems Inc. | Bifurcated tubular graft for treating tricuspid regurgitation |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
IL114589A (en) * | 1990-11-21 | 1999-12-22 | Roussel Uclaf | Intermediates for the preparation of the history of erythromycin |
FR2692579B1 (fr) * | 1992-06-19 | 1995-06-02 | Roussel Uclaf | Nouveaux dérivés de la picromycine, leur procédé de préparation et leur application comme médicaments. |
FR2697524B1 (fr) * | 1992-11-05 | 1994-12-23 | Roussel Uclaf | Nouveaux dérivés de l'érythromycine, leur procédé de préparation et leur application comme médicaments. |
US5527780A (en) * | 1992-11-05 | 1996-06-18 | Roussel Uclaf | Erythromycin derivatives |
HRP930014A2 (en) * | 1993-01-08 | 1994-08-31 | Pliva Pharm & Chem Works | 9-deoxo-9a-aza-11-deoxy-9a-homoeritromycin a 9a, 11-cyclic carbamates |
JPH07219312A (ja) * | 1993-12-10 | 1995-08-18 | Canon Inc | 画像形成装置 |
-
1994
- 1994-12-09 FR FR9414807A patent/FR2727969B1/fr not_active Expired - Lifetime
-
1995
- 1995-11-30 US US08/565,252 patent/US5786339A/en not_active Expired - Lifetime
- 1995-12-06 AT AT95402744T patent/ATE172467T1/de active
- 1995-12-06 DK DK95402744T patent/DK0716093T3/da active
- 1995-12-06 EP EP95402744A patent/EP0716093B1/fr not_active Expired - Lifetime
- 1995-12-06 ES ES95402744T patent/ES2123934T3/es not_active Expired - Lifetime
- 1995-12-06 DE DE69505487T patent/DE69505487T2/de not_active Expired - Lifetime
- 1995-12-08 KR KR1019950047655A patent/KR100371473B1/ko not_active IP Right Cessation
- 1995-12-08 CA CA002164798A patent/CA2164798C/fr not_active Expired - Lifetime
- 1995-12-08 JP JP34510695A patent/JP4083824B2/ja not_active Expired - Lifetime
- 1995-12-08 HU HU9503524A patent/HU215192B/hu unknown
- 1995-12-08 ZA ZA9510447A patent/ZA9510447B/xx unknown
- 1995-12-08 CN CN95121426A patent/CN1067077C/zh not_active Expired - Lifetime
- 1995-12-08 AU AU40324/95A patent/AU697876B2/en not_active Expired
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN100351238C (zh) * | 1998-11-10 | 2007-11-28 | 艾文蒂斯药品公司 | 新的红霉素衍生物、其制备方法和作为药物的用途 |
Also Published As
Publication number | Publication date |
---|---|
HU9503524D0 (en) | 1996-02-28 |
HU215192B (hu) | 1998-10-28 |
EP0716093B1 (fr) | 1998-10-21 |
KR100371473B1 (ko) | 2003-07-22 |
ZA9510447B (en) | 1996-12-09 |
CA2164798A1 (fr) | 1996-06-10 |
DK0716093T3 (da) | 1999-06-28 |
FR2727969B1 (fr) | 1997-01-17 |
ES2123934T3 (es) | 1999-01-16 |
EP0716093A1 (fr) | 1996-06-12 |
HUT74075A (en) | 1996-10-28 |
JPH08231583A (ja) | 1996-09-10 |
DE69505487D1 (de) | 1998-11-26 |
AU4032495A (en) | 1996-06-20 |
DE69505487T2 (de) | 1999-05-12 |
JP4083824B2 (ja) | 2008-04-30 |
KR960022553A (ko) | 1996-07-18 |
US5786339A (en) | 1998-07-28 |
CN1067077C (zh) | 2001-06-13 |
AU697876B2 (en) | 1998-10-22 |
ATE172467T1 (de) | 1998-11-15 |
CA2164798C (fr) | 2007-03-20 |
FR2727969A1 (fr) | 1996-06-14 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN1067077C (zh) | 新的红霉素衍生物及其制备方法和药物用途 | |
CN1033273C (zh) | 新型红霉素衍生物及其制备方法和作为药物的用途 | |
US4345069A (en) | Deformyltylosin derivatives | |
EP2089408B1 (en) | Macrolide synthesis process | |
JP4102440B2 (ja) | 新規なエリスロマイシン誘導体、それらの調製方法及びそれらの医薬品としての使用 | |
CN100351238C (zh) | 新的红霉素衍生物、其制备方法和作为药物的用途 | |
CN1028428C (zh) | 23-(c1-c6烷基肟)-ll-f28249化合物的制备方法 | |
CN1280585A (zh) | 从9a-氮杂大环内酯类衍生的新3,6-半缩酮类 | |
CN1109890A (zh) | 9-脱氧-9a-氮杂-9a-高红霉素,A的9a-N-(N′-氨基甲酰基)和9a-N-(N′-硫代氨基甲酰基衍生物 | |
CN1238364C (zh) | 红霉素衍生物,其制备方法及其作为药物的用途 | |
EP0316128B1 (en) | Antibacterial 9-deoxo-9a-allyl and propargyl-9a-aza-9a-homoerythromycin a derivatives | |
CN1178951C (zh) | 新型红霉素衍生物,其制法及其作为药物的应用 | |
JP5188520B2 (ja) | 新規なエリスロマイシン誘導体、製造方法及び医薬としての利用 | |
SE448385B (sv) | 4"-deoxi-4"-acylamido-derivat av erytromycin-a | |
CN1246327C (zh) | 新型8a-和9a-15-元内酰胺 | |
FR2702480A1 (fr) | Nouveaux dérivés de l'érythromycine, leur procédé de préparation et leur application comme médicaments. | |
CN1224626C (zh) | β-D-5-硫代木糖衍生物、其制备方法及医疗用途 | |
JPS5896098A (ja) | エリスロマイシンa誘導体 | |
KR100467707B1 (ko) | 클래리트로마이신의 제 2결정형의 제조 방법 | |
JP4583601B2 (ja) | 新規の6−デオキシエリスロマイシン誘導体、それらの製造方法及びそれらの薬剤としての使用 | |
JPS6159637B2 (zh) | ||
CN1523030A (zh) | C10高碳糖及其衍生物、制备方法及用途 | |
JPS6121237B2 (zh) | ||
JPS6121238B2 (zh) | ||
JPH0278695A (ja) | エリスロマイシン誘導体 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
C56 | Change in the name or address of the patentee |
Owner name: LUSUO ROUSSEL UCLAF CO., LTD. Free format text: FORMER NAME OR ADDRESS: ROUSSEL-UCLAF Owner name: HOECHST MARION ROUSSEL INC. Free format text: FORMER NAME OR ADDRESS: LUSUO ROUSSEL UCLAF CO., LTD. Owner name: VENTIS PHARMA S.A. Free format text: FORMER NAME OR ADDRESS: HOECHST MARION ROUSSEL INC. |
|
CP03 | Change of name, title or address |
Address after: French Anthony Patentee after: AVENTIS PHARMA S.A. Address before: French AUX Patentee before: Hoechst Marion Roussel Address after: French Roman Patentee after: Roussel-Uclaf Address before: French Roman Patentee before: ROUSSEL UCLAF Address after: French AUX Patentee after: Hoechst Marion Roussel Address before: French Roman Patentee before: Roussel-Uclaf |
|
CX01 | Expiry of patent term |
Granted publication date: 20010613 |
|
EXPY | Termination of patent right or utility model |